Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Biological Psychiatry|March 11, 1999
CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modificationJ A Cervilla, C Russ, C Holmes, et al.
Experientia|December 15, 1984
The role of phosphoenolpyruvate in insulin secretion: the effect of L-phenylalanineT A Chatterton, C H Reynolds, N R Lazarus, et al.
Biotechnology and Bioengineering|July 20, 1995
Equilibria for the adsorption of antibiotics onto neutral polymeric sorbents: Experimental and modeling studiesM V Chaubal, G F Payne, C H Reynolds, et al.
Australian and New Zealand Journal of Ophthalmology|July 31, 1998
Effects of peripheral flicker masking on M- and P-pathway responseC H Reynolds, D P Crewther, S G Crewther, et al.
The Biochemical Journal|May 15, 1982
Immunological and kinetic properties of pyruvate kinase in rat pancreatic isletsT A Chatterton, C H Reynolds, N R Lazarus, et al.
British Journal of Pharmacology|November 13, 2001
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transportersC M Pariante, A Makoff, S Lovestone, et al.
FEBS Letters|January 6, 2000
The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activityK Leroy, R Menu, J L Conreur, et al.
Biological Psychiatry|March 12, 1998
Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's diseaseC Holmes, C Russ, G Kirov, et al.
Brain Research. Molecular Brain Research|February 19, 2004
Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsyG M Gibb, R de Silva, T Revesz, et al.
Neuroscience|December 12, 2001
Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cellsT G Mack, R Dayanandan, M Van Slegtenhorst, et al.
Pageof 16